Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May 1;397(10285):1599-1601.
doi: 10.1016/S0140-6736(21)00712-1.

Tocilizumab in COVID-19: some clarity amid controversy

Shruti Gupta  1 , David E Leaf  2
Affiliations
Comment

Tocilizumab in COVID-19: some clarity amid controversy

Shruti Gupta et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment in

  • Allocated but not treated: the silent 16.
    Lee TC, Morris AM, Schwartz IS, McDonald EG. Lee TC, et al. Lancet. 2022 May 7;399(10337):1775. doi: 10.1016/S0140-6736(22)00377-4. Lancet. 2022. PMID: 35526549 Free PMC article. No abstract available.

Comment on

References

    1. Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636–1643. - PMC - PubMed
    1. Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384:693–704. - PMC - PubMed
    1. Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA. 2020;117:10970–10975. - PMC - PubMed
    1. Gupta S, Wang W, Hayek SS, et al. Association between early treatment with tocilizumab and mortality among critically ill patients with covid-19. JAMA Intern Med. 2021;181:41–51. - PMC - PubMed
    1. Stone JH, Frigault MJ, Serling-Boyd NJ, et al. Efficacy of tocilizumab in patients hospitalized with covid-19. N Engl J Med. 2020;383:2333–2344. - PMC - PubMed

Substances

LinkOut - more resources